Bone Marrow Transplantation in Adults with Thalassemia: Treatment and Long‐Term Follow‐Up
The DOI matches its Crossref record.
Abstract
A bstract: Current regular blood transfusion programs and chelation treatment have considerably improved survival of patients with thalassemia, which resulted in a larger proportion of adult patients. However, disease‐ and treatment‐related complications in these patients progress over time, causing severe morbidity and shortened life expectancy. Stem cell transplantation still remains the only cure currently available for patients with thalassemia. This study updates transplant outcomes in 107 adult patients with median age of 22 years (range, 17‐35 years) who received bone marrow transplantation (BMT) from human leukocyte antigen (HLA)‐identical related donors between 1988 and 1996 (group A) and describes the results of BMT in 15 adult patients with median age of 21 years (range, 17‐31 years) who were treated with a new treatment protocol (Protocol 26) between 1997 and 2003 (group B). The probability of survival, event‐free survival, nonrejection mortality, and rejection for group A patients were 66%, 62%, 37%, and 4%, respectively, with a median follow‐up of 12 years (range, 8.3‐16.2 years). Group B patients treated with the new protocol had some improvement in thalassemia‐free survival (67%) and lower transplant‐related mortality (27%) than that of previous protocols. However, transplant‐related mortality in these high‐risk patients remains elevated. Current myeloablative BMT in adult patients is characterized by higher transplant‐related toxicity due to an advanced phase of disease. Although this new approach to transplant adult patients with a reduced‐dose intensity‐conditioning regimen has improved thalassemia‐free survival, transplant‐related mortality in these high‐risk patients remains elevated.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Higgs, D. R., Engel, J. D., & Stamatoyannopoulos, G. (2012) · The Lancet · doi:10.1016/s0140-6736(11)60283-3 · Cited by 434
Rachmilewitz, E. A., & Giardina, P. J. (2011) · Blood · doi:10.1182/blood-2010-08-300335 · Cited by 417
Angelucci, E., Matthes-Martin, S., Baronciani, D., Bernaudin, F., Bonanomi, S., Cappellini, M. D., Dalle, J.-H., Di Bartolomeo, P., de Heredia, C. D., Dickerhoff, R., et al. (2014) · Haematologica · doi:10.3324/haematol.2013.099747 · Cited by 399
Vento, S., Cainelli, F., & Cesario, F. (2006) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(06)70437-6 · Cited by 211
Hematopoietic Stem Cell Transplantation in Thalassemia and Sickle Cell Anemia
Lucarelli, G., Isgro, A., Sodani, P., & Gaziev, J. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a011825 · Cited by 166
“The probabilities of survival, thalassemia-free survival, rejection mortality, and non-rejection mortality were 65%, 65%, 7%, and 28%, respectively (Gaziev et al. 2005).”
BackgroundSelf-citation
Metadata
- Authors
- GAZIEV, J., SODANI, P., POLCHI, P., ANDREANI, M., & LUCARELLI, G.
- Venue
- Annals of the New York Academy of Sciences
- Publisher
- Wiley
- Published
- 2005-11
- Volume
- 1054
- Issue
- 1
- Pages
- 196-205
- ISSN
- 0077-8923 (ISSN-L)
- 1749-6632
- OpenAlex
- W2137525579
- Cited by
- 100
- References
- 0
- FWCI
- 3.03
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Bone Marrow Transplantation in Adults with Thalassemia: Treatment and Long‐Term Follow‐Up. https://app.cochat.ai/papers/10.1196/annals.1345.024
- The paper
- GAZIEV, J., SODANI, P., POLCHI, P., ANDREANI, M., & LUCARELLI, G. (2005). Bone Marrow Transplantation in Adults with Thalassemia: Treatment and Long‐Term Follow‐Up. Annals of the New York Academy of Sciences. https://doi.org/10.1196/annals.1345.024
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.